Display Settings:

Format

Send to:

Choose Destination
    Vaccine. 2008 Nov 25;26(50):6293-4. Epub 2008 Sep 18.

    Cervical cancer vaccination: the real meaning of cross-protection and its impact on the prevention.

    Abstract

    Prophylactic VLP-based vaccines effectively prevent papillomavirus infections with a high level of antibodies and safety. An 18% increased efficacy against CIN 2+ lesions associated with HPVs 16/18 has been observed with the appliance of the HPV16/18 AS04 adjuvanted recombinant vaccine.

    PMID:
    18804508
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk